Neurotensin-regulated miR-133α is involved in proinflammatory signalling in human colonic epithelial cells and in experimental colitis

Gut

Volumn 64, Issue 7, 2015, Pages 1095-1104

  Law, Ivy Ka Man ^a   Bakirtzi, Kyriaki ^a   Polytarchou, Christos ^a   Oikonomopoulos, Angelos ^a   Hommes, Daniel ^a   Iliopoulos, Dimitrios ^a   Pothoulakis, Charalabos ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFTIPHILIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MICRORNA; MICRORNA 133ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; PHOSPHOPROTEIN; PROTEIN C JUN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; MIRN133 MICRORNA, MOUSE; NERVE PROTEIN; NEUROTENSIN TYPE 1 RECEPTOR;

2, 4, 6 TRINITROBENZENE SULFONIC ACID INDUCED COLITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; COLONIC EPITHELIAL CELL; COMPUTER MODEL; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DOWN REGULATION; EPITHELIUM CELL; EXPERIMENTAL COLITIS; GENE ACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; HCT116 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NCM 460 NTR1 CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; UPREGULATION; ANIMAL; COLITIS; COLON; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; COLITIS; COLON; EPITHELIAL CELLS; HCT116 CELLS; HUMANS; MICE; MICE, KNOCKOUT; MICRORNAS; NERVE TISSUE PROTEINS; NF-KAPPA B; RECEPTORS, NEUROTENSIN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84929069226     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-307329     Document Type: Article

References (57)

1. Polak JM, Sullivan SN, Bloom S.R., et al. Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature 1977; 270:183-4.
2. Castagliuolo I, Wang CC, Valenick L, et al. Neurotensin is a proinflammatory neuropeptide in colonic inflammation. J Clin Invest 1999; 103:843-9.
3. Tanaka K, Masu M, Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron 1990; 4:847-54.
4. Fassio A, Evans G, Grisshammer R., et al. Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody. Neuropharmacology 2000; 39:1430-42.
5. Koon HW, Kim YS, Xu H, et al. Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2, 4, 6,-trinitrobenzensulphonic acid-induced colitis. Proc Natl Acad Sci USA 2009; 106:8766-71.
6. Brun P, Mastrotto C, Beggiao E., et al. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2005; 288:G621-9.
7. Zhao D, Keates AC, Kuhnt-Moore S, et al. Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J Biol Chem 2001; 276:44464-71.
8. Sundman L, Saarialho-Kere U, Vendelin J., et al. Neuropeptide S receptor 1 expression in the intestine and skin-putative role in peptide hormone secretion. Neurogastroenterol Motil 2010; 22:79-87, e30.
9. da Silva L, Neves BM, Moura L, et al. Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochim Biophys Acta 2011; 1813:1863-71.
10. Bakirtzi K, Hatziapostolou M, Karagiannides I., et al. Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors. Gastroenterology 2011; 141:1749-61.e1.
11. Margolis KG, Gershon MD. Neuropeptides and inflammatory bowel disease. Curr Opin Gastroenterol 2009; 25:503-11.
12. Zhao D, Pothoulakis C. Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation. Peptides 2006; 27:2434-44.
13. Bugni JM, Rabadi LA, Jubbal K, et al. The neurotensin receptor-1 promotes tumor development in a sporadic but not an inflammation-associated mouse model of colon cancer. Int J Cancer 2012; 130:1798-805.
14. McKenna LB, Schug J, Vourekas A., et al. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010; 139:1654-64, 1664 e1.
15. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33.
16. Wu F, Zikusoka M, Trindade A., et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135:1624-35 e24.
17. Bian Z, Li L, Cui J., et al. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol 2011; 225:544-53.
18. Fasseu M, Treton X, Guichard C., et al. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS ONE 2010; 5:pii e13160.
19. Takagi T, Naito Y, Mizushima K., et al. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol and Hepatol 2010; 25:S129-33.
20. Wu F, Zhang S, Dassopoulos T., et al. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010; 16:1729-38.
21. Josse C, Bouznad N, Geurts P., et al. Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis. Am J Physiol Gastrointest Liver Physiol 2014; 306: G229-43.
22. Wang H, An H, Wang B., et al. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Cancer 2013; 49:3924-35.
23. Arndt GM, Dossey L, Cullen L.M., et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009; 9:374.
24. Sarver AL, French AJ, Borralho P.M., et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009; 9:401.
25. Dong Y, Zhao J, Wu C.W., et al. Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res 2013; 11:1051-60.
26. Ma Y, Zhang P, Yang J., et al. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J Cancer 2012; 130:2077-87.
27. Min/+) Models of Colon Cancer. PLoS ONE 2011; 6:e18501.
28. Li Z, Gu X, Fang Y., et al. microRNA expression profiles in human colorectal cancers with brain metastases. Oncol Lett 2012; 3:346-50.
29. Li Q, Lin X, Yang X., et al. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am J Physiol Heart Circ Physiol 2010; 298: H1340-7.
30. Feng Y, Niu LL, Wei W, et al. A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation. Cell Death Dis 2013; 4:e934.
31. Cui W, Zhang S, Shan C., et al. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. FEBS J 2013; 280:3962-74.
32. Zhao D, Bakirtzi K, Zhan Y., et al. Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells. J Biol Chem 2011; 286:6092-9.
33. Koon HW, Shih D, Karagiannides I., et al. Substance P modulates colitis-associated fibrosis. Am J Pathol 2010; 177:2300-9.
34. Koon HW, Zhao D, Xu H., et al. Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis. Am J Pathol 2008; 173:400-10.
35. Evers BM, Izukura M, Townsend CM Jr, et al. Neurotensin prevents intestinal mucosal hypoplasia in rats fed an elemental diet. Dig Dis Sci 1992; 37:426-31.
36. Maoret JJ, Pospai D, Rouyerfessard C., et al. Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: binding studies and RT-PCR experiments. Biochem Biophys Res Commun 1994; 203:465-71.
37. Gui X, Guzman G, Dobner P.R., et al. Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma. Peptides 2008; 29:1609-15.
38. Zhao D, Zhan Y, Koon H.W., et al. Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J Biol Chem 2004; 279:43547-54.
39. Zhao D, Zhan Y, Zeng H., et al. Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells. Int J Cancer 2007; 120:1652-6.
40. Zhao D, Kuhnt-Moore S, Zeng H., et al. Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. Am J Physiol Cell Physiol 2003; 284:C1397-404.
41. Zhao D, Zhan Y, Zeng H., et al. Neurotensin stimulates interleukin-8 expression through modulation of I kappa B alpha phosphorylation and p65 transcriptional activity: involvement of protein kinase C alpha. Mol Pharmacol 2005; 67:2025-31.
42. Rao PK, Kumar RM, Farkhondeh M, et al. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci USA 2006; 103:8721-6.
43. Chen X, Wang K, Chen J., et al. In vitro evidence suggests that miR-133a-mediated regulation of uncoupling protein 2 (UCP2) is an indispensable step in myogenic differentiation. J Biol Chem 2009; 284:5362-9.
44. Hua Y, Zhang Y, Ren J. IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a. J Cell Mol Med 2012; 16:83-95.
45. Roderburg C, Luedde M, Vargas Cardenas D, et al. miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol 2013; 58:736-42.
46. Castoldi G, di Gioia CRT, Bombardi C, et al. MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol 2012; 227:850-6.
47. Cominelli F, Nast CC, Clark B.D., et al. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990; 86:972-80.
48. Ferretti M, Casini-Raggi V, Pizarro T.T., et al. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest 1994; 94:449-53.
49. Casini-Raggi V, Kam L, Chong Y.J., et al. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995; 154:2434-40.
50. Huang Z, Shi T, Zhou Q., et al. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease. Gut 2014; 63:1247-57.
51. Wang Y, Li L, Moore B.T., et al. MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS ONE 2012; 7:e34641.
52. Mattera R, Ritter B, Sidhu S.S., et al. Definition of the consensus motif recognized by gamma-adaptin ear domains. J Biol Chem 2004; 279:8018-28.
53. Burman JL, Wasiak S, Ritter B., et al. Aftiphilin is a component of the clathrin machinery in neurons. FEBS Lett 2005; 579:2177-84.
54. Lui-Roberts WW, Ferraro F, Nightingale T.D., et al. Aftiphilin and gamma-synergin are required for secretagogue sensitivity of Weibel-Palade bodies in endothelial cells. Mol Biol Cell 2008; 19:5072-81.
55. Hirst J, Borner GH, Harbour M, et al. The aftiphilin/p200/gamma-synergin complex. Mol Biol Cell 2005; 16:2554-65.
56. Carvalho FA, Aitken JD, Gewirtz A.T., et al. TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage. Mucosal Immunol 2011; 4:102-11.
57. Funakoshi T, Yamashita K, Ichikawa N., et al. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice. J Crohns Colitis 2012; 6:215-25.